...
首页> 外文期刊>Acta Oto-Laryngologica Case Reports >Bisphosphonate-associated ear canal osteonecrosis: a case report and review of the literature
【24h】

Bisphosphonate-associated ear canal osteonecrosis: a case report and review of the literature

机译:双膦酸盐相关的耳道骨坏死:一例报道并文献复习

获取原文
           

摘要

AbstractBackground: Few cases of bisphosphonate-associated ear canal osteonecrosis (BPECO) have been reported, and there are no established management strategies for the diagnosis or treatment of BPECO.Patients: A 71-year-old female who was taking alendronate for osteoporosis was initially diagnosed with left-sided otitis externa. However, a mass and wide-ranging destruction of the temporal bone were subsequently found on a computed tomography scan. The patient’s biopsy findings were suggestive of inflammatory granulation tissue and osteitis, but there was no evidence of malignancy. So, we diagnosed her with BPECO. After surgical debridement and the cessation of the alendronate treatment, the patient’s symptoms improved rapidly.Conclusions: BPECO is not a very well-known condition and so is often misdiagnosed. Diagnostic methods and treatments for BPECO should be established in future studies.
机译:摘要背景:双膦酸盐相关性耳道骨坏死(BPECO)的报道很少,并且尚无确定的诊断或治疗BPECO的治疗策略。诊断为左侧外耳道炎。但是,随后在计算机断层扫描中发现了颞骨的大规模破坏。患者的活检结果提示有炎症性肉芽组织和骨炎,但没有恶性证据。因此,我们诊断出她患有BPECO。在进行外科手术清创术并停止使用阿仑膦酸盐治疗后,患者的症状迅速改善。结论:BPECO不是一种非常知名的疾病,因此经常被误诊。 BPECO的诊断方法和治疗应在以后的研究中建立。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号